TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2011

Preliminary efficacy of the anti-insulin-like growth factor type 1 receptor antibody figitumumab in patients with refractory Ewing sarcoma.

Heribert Juergens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.